ESTRO Brachytherapy for Prostate Cancer 2018

- Prospectively collected database - 2250 men treated with PBI - Period 1990 – 2004

- Overall: the actuarial FFbF at 10 years was 86 %

- Dose (BED <150 Gy vs >150 Gy) was the only significant predictor of FFbF (p<0,001) in intermediate risk patients

International Journal of Radiation Oncology, Biology, Physics, 2009, Vol.75(1), pp.16-22